1,3-dipropyl-8-cyclopentylxanthine has been researched along with xanthine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brackett, LE; Daly, JW | 1 |
Klotz, KN; Lindenborn-Fotinos, J; Lohse, MJ; Olsson, RA; Reddington, M; Schwabe, U | 1 |
Cohen, BE; Huang, Z; Jacobson, KA; Kim, YC; Lee, G; Pollard, HB; Sorscher, EJ | 1 |
Diekmann, M; Fülle, F; Hinz, S; Klotz, KN; Müller, CE; Schumacher, B; Weyler, S | 1 |
4 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and xanthine
Article | Year |
---|---|
Relaxant effects of adenosine analogs on guinea pig trachea in vitro: xanthine-sensitive and xanthine-insensitive mechanisms.
Topics: Adenosine; Animals; Carbachol; Deoxyadenosines; Guinea Pigs; In Vitro Techniques; Male; Muscle Relaxation; Receptors, Purinergic; Theophylline; Thionucleosides; Trachea; Xanthine; Xanthines | 1991 |
8-Cyclopentyl-1,3-dipropylxanthine (DPCPX)--a selective high affinity antagonist radioligand for A1 adenosine receptors.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Animals; Binding, Competitive; Blood Platelets; Cattle; Cerebral Cortex; Enzyme Activation; Humans; In Vitro Techniques; Isotope Labeling; Myocardium; Radioligand Assay; Rats; Receptors, Purinergic; Xanthine; Xanthines | 1987 |
8-cyclopentyl-1,3-dipropylxanthine and other xanthines differentially bind to the wild-type and delta F508 first nucleotide binding fold (NBF-1) domains of the cystic fibrosis transmembrane conductance regulator.
Topics: Adenosine; Binding, Competitive; Carrier Proteins; Cystic Fibrosis Transmembrane Conductance Regulator; DNA-Binding Proteins; Intracellular Signaling Peptides and Proteins; Kinetics; Mutagenesis, Site-Directed; Protein Structure, Tertiary; Xanthine; Xanthines | 1997 |
Improving potency, selectivity, and water solubility of adenosine A1 receptor antagonists: xanthines modified at position 3 and related pyrimido[1,2,3-cd]purinediones.
Topics: Adamantane; Adenosine A1 Receptor Antagonists; Animals; Cells, Cultured; Humans; Phosphates; Prodrugs; Rats; Solubility; Structure-Activity Relationship; Water; Xanthine; Xanthines | 2006 |